EUVIMED · CrossrefZeitschrift
Journal of Clinical and Experimental Hematology
ISSN 2834-3328 · Probiologists Limited
Neueste Artikel
Cardiac toxicities of Bruton’s tyrosine kinase inhibitors: The risk of pericarditis and cardiac tamponade
Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy
Taking BAFF-R targeting CAR T-cells on the road
Commentary: Three-dimensional transvaginal ultrasound diagnosis of interstitial ectopic pregnancy in a unicornuate uterus: A case report
Commentary on “Ultrasmall polyvinylpyrrolidone-modified iridium nanoparticles with antioxidant and anti-inflammatory activity for acute pancreatitis alleviation”
Gender disparity in the reticulocyte count of HIV-positive patients on HAART management in Ilorin
The tip of the reproductive screening iceberg: ‘Every mother and every fetus matters’
An overview of clinical, molecular, and therapeutic approaches to Niemann-Pick disease
How effective are antioxidants without fetal hemoglobin in tackling oxidative stress in sickle cell disease?
Acquired cutis laxa: Hematological insights and therapeutic implications in a paraneoplastic context
Commentary on “Beyond infantile hemangiomas: A glimpse into overlapping rare syndromes emphasizing the vigilant screening for PHACE and LUMBAR syndromes”
Artificial intelligence in hematology: A critical perspective
Assessment of quality of life in people living with hemophilia: A case study of Yaoundé Hemophilia Treatment Centre, Cameroon
Methionine adenosyltransferase 2A (MAT2A) inhibitors as single agents or in combination strategy for cancer therapy
A commentary on patient and caregiver perceptions of home blood transfusions in the United States
A commentary on ‘Association between the weight-adjusted-waist index and familial hypercholesterolemia: A cross-sectional study’
New indications for nailfold videocapillaroscopy in the assessment and diagnosis of rheumatic diseases
Reimagining blood delivery: Extending IoTdrone frameworks to hematology logistics
Neutropenia in myelosuppressed cancer patients treated with recombinant human erythropoietin (EPO)
EUVIMED